Moonshots with Peter Diamandis

Why We're Living in a Biological Singularity With Ben Lamm | MOONSHOTS Live #297

Mittwoch, 30. September 2026 · 44 min

MP3

Shownotes

The Mates sit down with Ben Lamm at MOONSHOTS Live 2026 to discuss why we’re entering a biological singularity, from Anthropic’s move into biology and scalable gene editing to the possibility of artificial wombs within the next 24 months.

This episode was filmed at Moonshots Live 2026. Learn more at moonshots.com

Get access to metatrends 10+ years before anyone else - qr.diamandis.com/metatrends

Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360

Salim Ismail is the founder of Open ExO, a GP at Exponential Venture Capital/The Organizational Singularity Fund and a sought after global speaker and thought leader.

Dave Blundin is the founder & GP of Link Ventures

Dr. Alexander Wissner-Gross is a computer scientist and founder of Reified

Ben Lamm is the co-founder and CEO of Colossal Biosciences, a biotechnology company using genetic engineering and AI to advance species preservation and de-extinction efforts.

–

This event is presented with:

Google (google.com)

Circle (circle.com)

Future Vision XPRIZE Partners:

Salesforce (salesforce.com)

ARK Invest (ark-invest.com)

Xsolla (xsolla.com)

Range (rangemp.com)

Build with Gemini XPRIZE Partner:

Google (google.com)

_

Connect with Peter:

⁠X⁠ (qr.diamandis.com/twitter)

⁠Instagram⁠ (qr.diamandis.com/instagram)

⁠Substack⁠ (substack.com/@peterdiamandis)

⁠Website⁠ (diamandis.com)

⁠Xprize⁠ (xprize.org)

⁠A360⁠ (abundance360.com)

Connect with Dave:

⁠Web⁠ (db2.ai)

⁠X⁠ (x.com/DaveBlundin?s=20)

⁠LinkedIn⁠ (linkedin.com/in/dave-blundin)

⁠Instagram⁠ (instagram.com/dave.blundin)

⁠TikTok⁠ (tiktok.com/@daveblundin)

Connect with Salim:

⁠LinkedIn⁠ (linkedin.com/in/salimismail)

⁠X⁠ (x.com/salimismail)

⁠Join Salim’s 10X Shift⁠ (openexo.com/10x-shift?channel=moonshots)

⁠Subscribe to Salim’s YouTube channel⁠ (youtube.com/channel/UCh2iw67YgoRcp-oYBn89c5g)

⁠Exponential Venture Capital⁠ (organizationalsingularity.fund)

Connect with Alex

⁠Website⁠ (alexwg.org)

⁠LinkedIn⁠ (linkedin.com/in/alexwg)

⁠X⁠ (x.com/alexwg)

Email

⁠Substack⁠ (theinnermostloop.substack.com)

⁠Spotify⁠ (open.spotify.com/show/1thtZk5vHTXbtDHezPT7tl)

⁠Threads (threads.com/@alexwissnergross)

Connect with Ben

Website (colossal.com)

X (x.com/BenLamm)

LinkedIn (linkedin.com/in/benlamm)

Instagram (instagram.com/benlamm)

Listen to MOONSHOTS:

Apple (qr.diamandis.com/applepodcast)

YouTube (qr.diamandis.com/youtube)

Follow MOONSHOTS:

Instagram (instagram.com/moonshots_pod)

TikTok (tiktok.com/@moonshots_pod)

X (x.com/moonshots_pod)

Threads (threads.com/@moonshots_pod)

–

*Recorded on September 25th, 2026

*The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice.

Disclosure: Peter Diamandis and/or his affiliated funds hold investments in Insilico Medicine and Life Biosciences, which are discussed in this episode. This content is for informational purposes only and is not investment or medical advice.

Learn more about your ad choices. Visit megaphone.fm/adchoices

0:00 / 0:00